Best Practice & Research Clinical Haematology
Volume 20, Issue 1 , Pages 85-90, March 2007

Can reduced-intensity allogeneic transplantation cure older adults with AML?

  • Rainer Storb, MD (Member and Head, Program in Transplantation Biology, Fred Hutchinson Cancer Research Center Professor of Medicine, University of Washington)

      Affiliations

    • Corresponding Author InformationTel.: +1 206 667 4407; Fax: +1 206 667 6124.

Fred Hutchinson Cancer Research Center, Clinical Research Division, Transplantation Biology Program, Fairview Avenue North, D5-310, PO Box 19024, Seattle, WA 98109-1024, USA

Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(06)00077-6

doi:10.1016/j.beha.2006.10.008

Best Practice & Research Clinical Haematology
Volume 20, Issue 1 , Pages 85-90, March 2007

Article Tools

* Image Usage & Resolution